XORTX Therapeutics (XRTX) Non-Current Assets (2020 - 2026)

XORTX Therapeutics' Non-Current Assets history runs 7 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• Quarterly Non-Current Assets changed 0.37% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 1.02% YoY) and the FY2025 annual result came in at $1.4 million, changed 0.32% from the prior year.
• Non-Current Assets was $1.4 million for Q1 2026 at XORTX Therapeutics, down from $1.4 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $1.5 million in Q2 2025 and bottomed at $1.4 million in Q1 2024.
• A 5-year average of $1.4 million and a median of $1.4 million in 2025 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2023 — Non-Current Assets fell 5.16% — and 2025, when it rose 2.41%.
• XORTX Therapeutics' Non-Current Assets stood at $1.5 million in 2022, then slipped by 5.16% to $1.4 million in 2023, then gained by 1.33% to $1.4 million in 2024, then gained by 0.32% to $1.4 million in 2025, then fell by 1.55% to $1.4 million in 2026.
• Business Quant data shows XRTX's Non-Current Assets at $1.4 million in Q1 2026, $1.4 million in Q4 2025, and $1.5 million in Q3 2025.